iBio
IBIO
#10099
Rank
S$86.11 M
Marketcap
S$1.73
Share price
-2.86%
Change (1 day)
66.71%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): S-$0.99

According to iBio's latest financial reports the company's current EPS (TTM) is S-$0.96. In 2025 the company made an earnings per share (EPS) of S-$2.23 an increase over its 2024 EPS that were of S-$8.28.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.99-55.49%
2025S-$2.23-73.08%
2024S-$8.28-93.88%
2023S-$135.34-8.14%
2022S-$147.3392.67%
2021S-$76.47-80.33%
2020S-$388.73-35.11%
2019S-$599.02-38.96%
2018S-$981.38-6.1%
2017S-$1,04536.67%
2016S-$764.7133.33%
2015S-$573.5350%
2014S-$382.36-53.85%
2013S-$828.44-7.14%
2012S-$892.16-64.1%
2011S-$2,48577.27%
2010S-$1,402144.44%
2009S-$573.5312.93%
2008S-$507.8812.2%
2007S-$452.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.13-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S-$0.66-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$10.73 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$0.22-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA